Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Menstrual Manipulation for Adolescents with Disabilities

Obstet Gynecol; 2016 Aug; ACOG Committee on Adolescent Health Care

The American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care have issued a committee opinion on menstrual manipulation for adolescents with physical and developmental disabilities. Among the ACOG conclusions and recommendations:

  • Optimal gynecologic health care for adolescents with disabilities is comprehensive; maintains confidentiality; is an act of dignity and respect toward the patient; maximizes the patient’s autonomy; avoids harm; and assesses and addresses the patient’s knowledge of puberty, menstruation, sexuality, safety, and consent.
  • Adolescents with disabilities may have other causes for menstrual irregularities.
  • In adolescents with disabilities, sexually transmitted infections (STIs) may be undiagnosed, underdiagnosed, or mistaken for urinary tract infections because the obstetrician–gynecologist may assume that the patient is not sexually active or the patient may not have the ability to feel or report symptoms.
  • If, after an evaluation, the adolescent, her family, and the obstetrician–gynecologist have decided that menstrual intervention is warranted, advantages and disadvantages of hormonal methods should be reviewed and individualized to each patient’s specific needs.
  • Complete amenorrhea may be difficult to achieve, and realistic expectations should be addressed with the patient and her caregivers.
  • Antiprostaglandin drugs, in adequate dosages based on the patient’s weight, decrease ovulatory menstrual bleeding by approximately 30 to 40%.
  • Combined oral contraceptives can be used continuously or for an extended period to attain optimal suppression.
  • Oral progestins in high doses, including progestin-only birth control pills, can be used daily to attempt menstrual suppression.
  • Use of depot medroxyprogesterone acetate (DMPA) results in relatively high rates of amenorrhea by the fourth dose (approximately 90% per 90-day cycle) and has a long history of clinical use to suppress menses.
  • The levonorgestrel intrauterine device (IUD) should be considered for any adolescent patient.
  • Hysterectomy for the purpose of cessation of normal menses may be considered only after other reasonable alternatives have been attempted.
  • Menstrual suppression before menarche and endometrial ablation are not recommended as treatments.

Citation:

Menstrual manipulation for adolescents with physical and developmental disabilities. Committee Opinion No. 668. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2016;128:e20–5.